Publikationen von Luis A. Pardo
Alle Typen
Zeitschriftenartikel (94)
61.
Zeitschriftenartikel
5 (1), e8858 (2010)
Characterization of Eag1 channel lateral mobility in rat hippocampal cultures by single-particle-tracking with quantum dots. PLoS ONE 62.
Zeitschriftenartikel
9 (2), S. 918 - 924 (2010)
EAG1, EAG2 and KCNN3 gene brain expression of isolated reared rats. Genes, Brain and Behavior 63.
Zeitschriftenartikel
2 (5), S. 745 - 755 (2010)
K+ channels as therapeutic targets in oncology. Future Medicinal Chemistry 64.
Zeitschriftenartikel
8, S. 982 - 1001 (2009)
Voltage-gated potassium channels as therapeutic targets. Nature Reviews Drug Discovery 65.
Zeitschriftenartikel
70 (2), S. 286 - 293 (2009)
Concept of a selective tumour therapy and its evaluation by near-infrared fluorescence imaging and flat-panel volume computed tomography in mice. European Journal of Radiology 66.
Zeitschriftenartikel
38 (3), S. 279 - 284 (2009)
The voltage dependence of hEag currents is not determined solely by membrane-spanning domains. European Biophysics Journal 67.
Zeitschriftenartikel
283 (52), S. 36234 - 36240 (2008)
Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors. Journal of Biological Chemistry 68.
Zeitschriftenartikel
68 (6), S. 1611 - 1613 (2008)
Eag1: an emerging oncological target. Cancer Research 69.
Zeitschriftenartikel
9 (6), S. 512 - 515 (2008)
Ion channels: functional expression and therapeutic potential in cancer. Colloquium on ion channels and cancer. EMBO Reports 70.
Zeitschriftenartikel
30, S. 162 - 173 (2008)
Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neurobiology of Disease 71.
Zeitschriftenartikel
155, S. 833 - 844 (2008)
Eag1 potassium channel immunohistochemistry in the CNS of adult rat and selected regions of human brain. Neuroscience 72.
Zeitschriftenartikel
12 (7), S. 837 - 843 (2008)
Eag1 as a cancer target. Expert Opinion on Therapeutic Targets 73.
Zeitschriftenartikel
67 (15), S. 7343 - 7349 (2007)
Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity. Cancer Research 74.
Zeitschriftenartikel
171 (2), S. 589 - 598 (2007)
Re-expression of a developmentally restricted potassium channel in autoimmune demyelination - Kv1.4 is implicated in oligodendroglial proliferation. American Journal of Pathology 75.
Zeitschriftenartikel
5, 41 (2006)
Overexpression of EagI potassium channels in clinical tumours. Molecular Cancer 76.
Zeitschriftenartikel
5, 42 (2006)
Ether à go-go potassium channel expression in soft tissue sarcoma patients. Molecular Cancer 77.
Zeitschriftenartikel
580 (21), S. 5059 - 5066 (2006)
Different relevance of inactivation and F468 residue in the mechanisms of hEag1 channel blockage by astemizole, imipramine and dofetilide. FEBS Letters 78.
Zeitschriftenartikel
580 (12), S. 2850 - 2852 (2006)
Potassium channels as tumour markers. FEBS Letters 79.
Zeitschriftenartikel
281 (19), S. 13030 - 13037 (2006)
Silencing the activity and proliferative properties of the human EagI potassium channel by RNA interference. Journal of Biological Chemistry 80.
Zeitschriftenartikel
280 (33), S. 29506 - 29512 (2005)
Glycosylation of Eag1 (Kv10.1) potassium channels - Intracellular trafficking and functional consequences. Journal of Biological Chemistry